Leeward Investments LLC MA Has $10.08 Million Stake in Genpact Limited (NYSE:G)

Leeward Investments LLC MA decreased its position in shares of Genpact Limited (NYSE:G) by 2.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 290,510 shares of the business services provider’s stock after selling 7,843 shares during the period. Leeward Investments LLC MA owned 0.16% of Genpact worth $10,084,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in G. FMR LLC increased its holdings in shares of Genpact by 8.1% during the 3rd quarter. FMR LLC now owns 17,644,694 shares of the business services provider’s stock worth $638,738,000 after purchasing an additional 1,327,435 shares during the period. Westfield Capital Management Co. LP increased its holdings in shares of Genpact by 18.1% during the 3rd quarter. Westfield Capital Management Co. LP now owns 2,948,433 shares of the business services provider’s stock worth $106,733,000 after purchasing an additional 452,612 shares during the period. Truist Financial Corp increased its holdings in shares of Genpact by 1,624.0% during the 3rd quarter. Truist Financial Corp now owns 350,400 shares of the business services provider’s stock worth $12,684,000 after purchasing an additional 330,075 shares during the period. Nordea Investment Management AB increased its stake in Genpact by 14.8% in the third quarter. Nordea Investment Management AB now owns 2,484,781 shares of the business services provider’s stock valued at $91,664,000 after acquiring an additional 321,032 shares during the period. Finally, Greenhaven Associates Inc. bought a new stake in Genpact in the fourth quarter valued at about $10,510,000. Institutional investors own 96.03% of the company’s stock.

Genpact Trading Up 0.7 %

NYSE G traded up $0.21 during trading hours on Friday, hitting $30.90. The company’s stock had a trading volume of 1,665,661 shares, compared to its average volume of 1,533,887. Genpact Limited has a twelve month low of $29.41 and a twelve month high of $44.63. The company has a quick ratio of 1.44, a current ratio of 1.44 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $5.57 billion, a P/E ratio of 9.01, a PEG ratio of 1.49 and a beta of 1.07. The stock has a fifty day moving average of $33.17 and a 200 day moving average of $34.16.

Genpact (NYSE:G) last issued its earnings results on Thursday, February 8th. The business services provider reported $0.68 EPS for the quarter, beating the consensus estimate of $0.65 by $0.03. Genpact had a net margin of 14.10% and a return on equity of 23.19%. The firm had revenue of $1.15 billion during the quarter, compared to the consensus estimate of $1.12 billion. Equities research analysts forecast that Genpact Limited will post 2.7 earnings per share for the current fiscal year.

Genpact Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 26th. Stockholders of record on Monday, March 11th were given a dividend of $0.153 per share. This is an increase from Genpact’s previous quarterly dividend of $0.14. The ex-dividend date of this dividend was Friday, March 8th. This represents a $0.61 annualized dividend and a dividend yield of 1.98%. Genpact’s dividend payout ratio is currently 17.78%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on G shares. StockNews.com cut shares of Genpact from a “strong-buy” rating to a “buy” rating in a research note on Friday, April 5th. Citigroup lowered their target price on shares of Genpact from $36.00 to $33.00 and set a “neutral” rating on the stock in a research note on Monday. Mizuho started coverage on shares of Genpact in a research note on Tuesday, January 30th. They issued a “neutral” rating and a $40.00 target price on the stock. JPMorgan Chase & Co. upped their price objective on shares of Genpact from $42.00 to $43.00 and gave the stock an “underweight” rating in a research note on Friday, February 9th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $40.00 price objective on shares of Genpact in a research note on Friday, February 9th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Genpact currently has a consensus rating of “Hold” and an average price target of $39.78.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.